Ketoconazol Tis Farmaceutic (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. Inhibiting ergosterol production weakens the membrane, leading to increased permeability and ultimately fungal cell death.

The specific dosing regimen for Ketoconazol Tis Farmaceutic is determined by the prescribing healthcare professional based on the infection type, severity, patient age and skin condition. The prescriber will provide detailed instructions on the amount to apply and frequency of use.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any possible risks before prescribing. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative treatments with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketoconazole belongs to the imidazole class, which is effective against a broad range of dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, ketoconazole offers a similar spectrum but may be preferred for its anti‑inflammatory properties in seborrheic dermatitis. Choice depends on infection type, resistance patterns and patient tolerance.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture, excessive heat and direct sunlight. Ensure the container is tightly closed to maintain product stability.

The medication is applied topically to the affected skin area. Clean and dry the skin, then spread a thin layer of the cream or ointment over the lesion as directed by the prescriber, usually once or twice daily, and continue for the prescribed duration.

Serious adverse reactions, though rare, include severe allergic responses such as angio‑edema, extensive contact dermatitis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and systemic hepatotoxicity with extensive use. Patients should seek immediate medical attention if they notice swelling, blistering, jaundice or other severe symptoms.

Individuals with a known hypersensitivity to ketoconazole, other imidazole antifungals, or any formulation components should avoid using the product. It should also be avoided on extensive broken skin, mucous membranes, or in patients with a history of severe drug reactions without medical supervision.